|
May 8
|
Standard BioTools Reports First Quarter 2024 Financial Results
|
|
Apr 25
|
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
|
|
Apr 25
|
Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024
|
|
Apr 16
|
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic?
|
|
Apr 8
|
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
|
|
Apr 3
|
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
|
|
Apr 2
|
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)?
|
|
Mar 19
|
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB)
|
|
Mar 18
|
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
|
|
Mar 5
|
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript
|
|
Mar 1
|
Standard BioTools Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
|
|
Feb 29
|
Q4 2023 Standard BioTools Inc Earnings Call
|
|
Feb 28
|
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ...
|
|
Feb 28
|
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 26
|
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
|
|
Dec 29
|
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
|
|
Dec 28
|
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools
|
|
Dec 26
|
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure
|
|
Dec 22
|
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
|
|
Dec 21
|
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
|